Gaithersburg, Md.—— OpGen, Inc., a commercial stage DNA analysis company, today announced the Argus® Whole Genome Mapping System continues to gain broad adoption among genome sequencing centers worldwide. Five leading international genomic sequencing centers have joined the growing list of centers utilizing OpGen’s technology to enhance their next-generation sequencing capabilities. The centers include The Genome […]
Marcy l’Etoile (France) and Lexington, MA (U.S.) –— bioMérieux and Quanterix announced today that they have entered into a strategic agreement that gives bioMérieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications. Under the agreement, Quanterix will deliver a new instrument and consumables based on its Simoa technology. bioMérieux […]
SOUTH SAN FRANCISCO, Calif.,– Fluidigm Corporation, today announced it ranked 185 on Deloitte’s Technology Fast 500™ list, which ranks the 500 fastest growing technology, media, telecommunications, life sciences, and clean technology companies in North America from2007 to 2011. Fluidigm grew 489% during this period. Fluidigm was the fastest growing Life Sciences company in the San […]
SAN DIEGO, Nov. — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported revenue of $22.9 million for the third quarter of 2012, an increase of 25% from revenue of $18.3 million in the second quarter of 2012 and a 68% increase compared to revenue of $13.6 million for […]
SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced it has filed litigation against NanoString Technologies, Inc., a privately-held company in Seattle, Washington, for false advertising, unfair competition, and unlawful trade practice in violation of the Lanham Act and corresponding sections of the California Business & Professional Code. The complaint was filed in federal […]
SOUTH SAN FRANCISCO, Calif. –– Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2012. Product revenue for the third quarter of 2012 was $12.6 million, an increase of 24% from $10.2 million in the third quarter of 2011. Product margin was a record 72% in the third quarter […]
SAN DIEGO and SAN FRANCISCO —— BioNano Genomics today announced the commercial rollout of its breakthrough Irys™ System, an intuitively designed genome mapping system that empowers genomics researchers with a new way of analyzing genomic DNA. Irys makes it possible to routinely and accurately detect genomic structural variation and to finish genome assemblies. Irys reveals […]
Madison, WI — BellBrook Labs today announced the awarding of a Phase II SBIR grant for $850,000 from the National Heart, Lung and Blood Institute to continue development of a specialized assay plate for primary epithelial cells. The innovative plate, called the ALI Assay Plate, is designed for culturing primary airway epithelial cells at an […]
SOUTH SAN FRANCISCO, Calif.,– Fluidigm Corporation (NASDAQ:FLDM) today introduced four new integrated fluidic circuits (IFCs) designed to meet the challenges associated with production genomics. These new offerings are expected to make substantial contributions to laboratories performing high sample throughput digital PCR, genotyping, and targeted panel testing. “Today, we unveil four innovative devices, each responding to […]
New instrument completes portfolio for customers with high-throughput applications Today Roche announced the global launch of its Cedex Bio HT Analyzer for the highly reliable determination of metabolites and substrates in mammalian and microbial cell fermentation. The Cedex Bio HT System offers very precise analytics, a broad test portfolio allowing flexible adaption of additional test […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
